CelVivo
CelVivo is a Danish biotech company that develops clinostat-based 3D cell culture hardware (ClinoStar 2 and ClinoReactor) plus consumables and a cloud monitoring service, selling primarily to academic researchers, pharmaceutical/biotech firms, and medical research groups via direct sales and a global distributor network spanning 35+ countries.
- Company typePrivate
- Founded2014
- HeadquartersOdense, Denmark
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What CelVivo does
CelVivo ApS is a Danish biotechnology company founded in 2014 and headquartered in Odense, Denmark, with a wholly-owned US subsidiary (CelVivo, Inc.) in Chevy Chase, Maryland. It develops and sells clinostat-based 3D cell culture systems that grow cells in a stress-free, low-shear laminar-flow environment intended to mimic in vivo physiological conditions for organoid development, tissue engineering, and related research. Its core hardware products are the ClinoStar 2 (a clinostat integrated into a CO2 incubator) and the ClinoReactor (a patent-pending single-use bioreactor with a 10 mL growth chamber), supplemented by a Hypoxia Module accessory and the CelVivo Cloud remote-monitoring service. The technical narrative centers on the "RARE" framework — Relevance, Abundance, Reproducibility, Ease — claiming up to 100% utilization of cell cultures and superior organoid growth versus conventional methods.
CelVivo sells capital equipment, single-use consumables, and after-sales service to academic and research institutions, pharmaceutical and biotechnology companies, and medical research groups. The business model is hardware-led with a consumable and service tail: pricing is quote-based against an unpublished price list, payment terms are typically 30 days from invoice, and up to 50% advance payment may be required. Distribution combines direct sales — handled in-house for the Americas via the US subsidiary — with a network of named regional distributors covering APAC (e.g., Yamato Scientific in Japan, Sino BioTool in China), Central and Southern Europe (e.g., ALAB in Poland, Cytosens in Italy and Spain), the Middle East and Africa (Seperations in South Africa), and additional partners in Singapore, Korea, India, Taiwan, the Czech Republic, and Switzerland. A co-development partnership with TheWell Bioscience integrates Vitrogel hydrogel into the ClinoReactor workflow for cell lines with insufficient natural ECM production.
The company is privately held and bootstrapped, with 1-10 employees and no disclosed funding rounds, revenue, or institutional investors in the available source material. It protects its technology through registered trademarks for ClinoStar and ClinoReactor and a patent-pending filing on the ClinoReactor bioreactor. The operating footprint spans roughly 35+ countries, though no quantitative revenue or growth data is publicly disclosed, and named customer logos are predominantly individual academic and research institutions rather than large anchor enterprise accounts.
CelVivo firmographics
Firmographics- Name
- CelVivo
- Legal name
- CelVivo ApS
- Website
- https://celvivo.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- CelVivo is a Danish biotech company that develops clinostat-based 3D cell culture hardware (ClinoStar 2 and ClinoReactor) plus consumables and a cloud monitoring service, selling primarily to academic researchers, pharmaceutical/biotech firms, and medical research groups via direct sales and a global distributor network spanning 35+ countries.
- Ownership category
- akta.pro rank
CelVivo industry classification
Industry- Product category
- 3D Cell Culture Laboratory Instruments
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG)
- akta.pro secondary industry
- Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors) (HLAAAJAC)
Keywords
Where CelVivo is headquartered
LocationHeadquarters
- HQ city
- Odense
- HQ country
- Denmark
- HQ region
- Europe
Offices3 records
Markets served
CelVivo business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- 3D Cell Culture Equipment Sales: Sale of ClinoStar and ClinoReactor systems for 3D cell culture, including hardware and control units. The ClinoStar has a 1-year warranty from delivery date.
- Consumables: Sale of ClinoReactor consumables. The ClinoReactor has a shelf life of 1 year and is sterilized via e-beam. Operating time in incubator is 10 days. Consumables are not covered by warranty.
- After-Sales Service and Repairs: CelVivo provides after-sales service and repairs on all products. Cost for repair and transport is covered by the buyer if outside warranty.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Annual | Custom pricing based on product configuration and volume |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels9 records
CelVivo product offering
Product offeringCore offering
CelVivo designs, manufactures, and sells hardware and consumables for 3D cell culture. Its flagship ClinoStar 2 system is a clinostat that fits inside a standard CO2 incubator to grow organoids and tissue in a low-shear, stress-free environment. The company complements the platform with the ClinoReactor single-use bioreactor, a Hypoxia Module accessory, and the Celvivo Cloud remote monitoring service.
Product overview
CelVivo offers a unified 3D cell culture system centered on the ClinoStar 2 platform, a clinostat-based device that incorporates directly into standard CO2 incubators. The system is complemented by the ClinoReactor, a single-use all-in-one bioreactor with a 10 mL growth chamber, and the Hypoxia Module for low-oxygen research applications. The Celvivo Cloud service adds remote monitoring and control capabilities, allowing researchers to monitor experiments from any location. Together, these products enable stress-free 3D cell and organoid culture with full reproducibility and relevance to in vivo conditions.
Differentiator
Problem solved
Functional benefit
Brands
- ClinoStar: A clinostat for 3D cell culture incorporated in a CO2 incubator, allowing culture of cells in 3D in a single unit. The most user-friendly system for working with organoids.
- ClinoReactor
- ClinoStar 2
- Hypoxia Module
- Celvivo Cloud
Products and services
- ClinoStar 2 The ClinoStar 2 is a clinostat for 3D cell culture that fits inside a standard CO2 incubator, enabling users to culture cells in 3D within a single unit. It provides a stress-free, low-shear environment for organoid development and tissue engineering, with remote monitoring via Celvivo Cloud, push-button auto decontamination, and stand-alone ergonomic design that eliminates the need for laminar flow bench work. It is sold to academic researchers, pharmaceutical R&D teams, and biotech laboratories.
- ClinoReactor The ClinoReactor is a single-use, all-in-one bioreactor with a 10 mL growth culture chamber, semi-permeable membrane for CO2 equilibrium, and an integrated humidification system. Its front wall doubles as a click-on/off lid, providing petri-dish-like access to the chamber, and it operates for 10 days inside an incubator with a one-year shelf life and e-beam sterilization. It is sold as a consumable used with the ClinoStar platform for 3D cell culture workflows.
- Hypoxia Module The Hypoxia Module is an add-on for the ClinoStar system that allows researchers to control oxygen conditions, enabling experiments under low-oxygen (hypoxic) environments for studying tumor microenvironments and other oxygen-related biological questions.
- Celvivo Cloud Celvivo Cloud is a cloud-based remote monitoring and control service that lets ClinoStar users monitor and manage their cell culture environment from any device, anywhere in the world. It is offered to ClinoStar owners as an add-on service.
Quantifiable outcome
- Up to 100% utilization of cell cultures
- +2 more outcomes
Companies that use CelVivo
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
CelVivo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
CelVivo partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- TheWell BiosciencecoreCelVivo has partnered with TheWell Bioscience to integrate Vitrogel hydrogel matrix into the ClinoStar workflow. This collaboration addresses cell lines where natural ECM production falls short, providing animal-free extracellular balance. Vitrogel allows cells to communicate, connect, and behave like true 3D cultures. The partnership includes joint application notes and is designed to improve research outcomes for problematic cell lines.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
CelVivo competitors and assessment
Company assessmentDirect peers
- InSphero: InSphero develops 3D cell culture technologies and organoid-based assay platforms for drug discovery. Highly comparable as a direct peer in 3D cell culture and organoid technology, though more services-led than CelVivo's hardware-led model.
- Stemcell Technologies: Stemcell Technologies provides reagents, tools, and instruments for cell culture, including organoid and 3D culture workflows. Comparable in serving the same academic and pharma researcher base with cell culture and 3D culture solutions.
Broad incumbents
- Corning Life Sciences: Corning offers Matrigel, spheroid microplates, and a wide portfolio of cell culture consumables. Comparable as a broad incumbent in cell culture and 3D culture, with much greater scale and distribution.
- Thermo Fisher Scientific: Thermo Fisher's Gibco and Nunc brands dominate cell culture media, reagents, and instruments. Comparable as a broad incumbent in the lab cell culture ecosystem, including emerging 3D culture offerings.
- Lonza: Lonza provides cell and gene therapy manufacturing, bioreactors, and cell culture solutions. Comparable as a broad incumbent in bioprocess and cell culture, with overlapping bioreactor expertise.
- Sartorius: Sartorius supplies bioprocessing equipment, including single-use bioreactors and cell culture analytics. Comparable as a broad incumbent whose bioreactor and single-use consumable portfolio overlaps with CelVivo's ClinoReactor.
Emerging players
- MIMETAS: MIMETAS develops organ-on-chip platforms (OrganoPlate) for 3D cell culture and disease modeling. Comparable as an emerging player in 3D cell culture with a different enabling technology (microfluidics) but overlapping pharma/research customer base.
- CN Bio: CN Bio builds organ-on-chip and microphysiological systems for drug discovery. Comparable as an emerging 3D cell culture player with overlapping pharma customer base and disease-modeling applications.
- Emulate: Emulate develops organ-on-chip technology (Liver-Chip, etc.) for preclinical testing. Comparable as an emerging player in human-relevant in vitro models, competing for pharma preclinical mindshare against CelVivo.
Regional players
- Reprocell: Reprocell provides iPSC-derived cells, organoids, and 3D culture services, primarily in Japan/APAC. Comparable as a regional player in 3D cell culture and organoid services with limited direct overlap in CelVivo's European/North American base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
CelVivo social profiles
Digital presenceCelVivo financial estimates
Financial estimateRevenue estimate
Valuation estimate
CelVivo leadership team
Management profileNumber of profiles
CelVivo subsidiaries and ownership
Company hierarchySubsidiaries1 record
CelVivo funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CelVivo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CelVivo
What does CelVivo do?
CelVivo designs, manufactures, and sells hardware and consumables for 3D cell culture. Its flagship ClinoStar 2 system is a clinostat that fits inside a standard CO2 incubator to grow organoids and tissue in a low-shear, stress-free environment. The company complements the platform with the ClinoReactor single-use bioreactor, a Hypoxia Module accessory, and the Celvivo Cloud remote monitoring service.
Is CelVivo a public or private company?
CelVivo is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CelVivo founded?
CelVivo was founded in 2014. It employs 1 to 10 people.
Where is CelVivo based?
CelVivo is headquartered in Odense, Denmark, in the Europe region.
How does CelVivo make money?
Three revenue lines are on record. 3D Cell Culture Equipment Sales are the primary driver. The others are consumables and after-Sales Service and Repairs.
Who are CelVivo's main competitors?
Direct peers on record are InSphero and Stemcell Technologies. Broad incumbents are Corning Life Sciences, Thermo Fisher Scientific, Lonza and Sartorius. Emerging players are MIMETAS, CN Bio and Emulate. Reprocell is listed as a regional player.
Does CelVivo have an API?
No public API is recorded for CelVivo.
What industry is CelVivo in?
CelVivo's product category is 3D Cell Culture Laboratory Instruments. Its primary akta.pro industry code is HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers), with a secondary code of HLAAAJAC, Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors). Its NAICS code is 339112 and its SIC code is 3841.